{"nctId":"NCT02662569","briefTitle":"Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia","startDateStruct":{"date":"2016-04-14","type":"ACTUAL"},"conditions":["Diabetes, Hyperlipidemia, Mixed Dyslipidemia"],"count":986,"armGroups":[{"label":"Atorvastatin (Q2W)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Atorvastatin","Other: Placebo"]},{"label":"Atorvastatin (QM)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Atorvastatin","Other: Placebo"]},{"label":"Evolocumab Q2W + Atorvastatin","type":"EXPERIMENTAL","interventionNames":["Biological: Evolocumab","Drug: Atorvastatin"]},{"label":"Evolocumab QM + Atorvastatin","type":"EXPERIMENTAL","interventionNames":["Biological: Evolocumab","Drug: Atorvastatin"]}],"interventions":[{"name":"Evolocumab","otherNames":["AMG 145","Repatha"]},{"name":"Atorvastatin","otherNames":["Lipitor"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Males and females with type 2 diabetes (receiving pharmacologic treatment for at least 6 months or longer) with stable diabetes therapy\n* Lipid-lowering therapy must be unchanged for at least 4 weeks or more\n* Subjects receiving statin therapy at screening must have a fasting LDL-C of greater than or equal to 100 mg/dL\n* Subjects not receiving statin therapy at screening must have a fasting LDL-C of greater than or equal to 130 mg/dL\n\nExclusion criteria:\n\n* New York Heart Association (NYHA) class III or IV heart failure\n* Uncontrolled cardiac arrhythmia\n* Uncontrolled hypertension\n* Type 1 diabetes or poorly controlled type 2 diabetes\n* Uncontrolled hypothyroidism or hyperthyroidism.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change From Baseline in LDL-C at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.94","spread":"3.48"},{"groupId":"OG001","value":"0.99","spread":"3.31"},{"groupId":"OG002","value":"-65.35","spread":"3.09"},{"groupId":"OG003","value":"-69.05","spread":"2.96"}]}]}]},{"type":"PRIMARY","title":"Percent Change From Baseline in LDL-C at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.10","spread":"3.66"},{"groupId":"OG001","value":"2.63","spread":"3.41"},{"groupId":"OG002","value":"-64.66","spread":"3.20"},{"groupId":"OG003","value":"-62.30","spread":"3.02"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in LDL-C at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.1","spread":"4.1"},{"groupId":"OG001","value":"-8.8","spread":"4.0"},{"groupId":"OG002","value":"-64.6","spread":"3.6"},{"groupId":"OG003","value":"-71.9","spread":"3.6"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in LDL-C at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","spread":"4.2"},{"groupId":"OG001","value":"-7.3","spread":"4.1"},{"groupId":"OG002","value":"-63.9","spread":"3.7"},{"groupId":"OG003","value":"-66.1","spread":"3.7"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Non-HDL-C at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.33","spread":"3.05"},{"groupId":"OG001","value":"0.33","spread":"2.95"},{"groupId":"OG002","value":"-56.57","spread":"2.70"},{"groupId":"OG003","value":"-59.08","spread":"2.63"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Non-HDL-C at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.87","spread":"3.20"},{"groupId":"OG001","value":"1.30","spread":"3.03"},{"groupId":"OG002","value":"-55.76","spread":"2.79"},{"groupId":"OG003","value":"-52.92","spread":"2.69"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B100 at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.97","spread":"3.31"},{"groupId":"OG001","value":"-1.52","spread":"2.99"},{"groupId":"OG002","value":"-54.96","spread":"3.07"},{"groupId":"OG003","value":"-56.37","spread":"2.72"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B100 at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.17","spread":"3.42"},{"groupId":"OG001","value":"-0.26","spread":"3.03"},{"groupId":"OG002","value":"-53.90","spread":"3.14"},{"groupId":"OG003","value":"-49.68","spread":"2.75"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Cholesterol at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.89","spread":"2.30"},{"groupId":"OG001","value":"-0.25","spread":"2.18"},{"groupId":"OG002","value":"-38.64","spread":"2.04"},{"groupId":"OG003","value":"-39.74","spread":"1.95"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Cholesterol at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.40","spread":"2.40"},{"groupId":"OG001","value":"0.67","spread":"2.24"},{"groupId":"OG002","value":"-37.82","spread":"2.10"},{"groupId":"OG003","value":"-35.22","spread":"1.99"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Cholesterol/HDL-C Ratio at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.03","spread":"2.38"},{"groupId":"OG001","value":"-2.03","spread":"2.41"},{"groupId":"OG002","value":"-41.06","spread":"2.11"},{"groupId":"OG003","value":"-45.70","spread":"2.17"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Cholesterol/HDL-C Ratio at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.22","spread":"2.49"},{"groupId":"OG001","value":"-1.22","spread":"2.47"},{"groupId":"OG002","value":"-40.72","spread":"2.18"},{"groupId":"OG003","value":"-41.78","spread":"2.21"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B100/Apolipoprotein A1 Ratio at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.60","spread":"3.30"},{"groupId":"OG001","value":"-1.02","spread":"3.09"},{"groupId":"OG002","value":"-55.60","spread":"3.07"},{"groupId":"OG003","value":"-57.75","spread":"2.82"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B100/Apolipoprotein A1 Ratio at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.23","spread":"3.39"},{"groupId":"OG001","value":"-0.10","spread":"3.16"},{"groupId":"OG002","value":"-54.98","spread":"3.12"},{"groupId":"OG003","value":"-51.80","spread":"2.86"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Mean LDL-C at Weeks 10 and 12 of Less Than 70 mg/dL (1.8 mmol/L)","description":null,"paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.7","spread":null},{"groupId":"OG001","value":"19.4","spread":null},{"groupId":"OG002","value":"90.1","spread":null},{"groupId":"OG003","value":"91.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With LDL-C Less Than 70 mg/dL (1.8 mmol/L) at Week 12","description":null,"paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20.9","spread":null},{"groupId":"OG001","value":"21.3","spread":null},{"groupId":"OG002","value":"88.2","spread":null},{"groupId":"OG003","value":"90.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lipoprotein(a) at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.89","spread":"17.49"},{"groupId":"OG001","value":"8.48","spread":"9.49"},{"groupId":"OG002","value":"-38.63","spread":"13.67"},{"groupId":"OG003","value":"-42.29","spread":"8.49"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lipoprotein(a) at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.53","spread":"21.78"},{"groupId":"OG001","value":"7.47","spread":"10.40"},{"groupId":"OG002","value":"-35.93","spread":"16.47"},{"groupId":"OG003","value":"-37.85","spread":"9.02"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Triglycerides at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.54","spread":"5.27"},{"groupId":"OG001","value":"8.48","spread":"4.48"},{"groupId":"OG002","value":"-6.48","spread":"4.70"},{"groupId":"OG003","value":"-7.15","spread":"4.02"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Triglycerides at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.50","spread":"5.36"},{"groupId":"OG001","value":"8.07","spread":"4.57"},{"groupId":"OG002","value":"-5.91","spread":"4.75"},{"groupId":"OG003","value":"-4.24","spread":"4.09"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in HDL-C at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.25","spread":"2.19"},{"groupId":"OG001","value":"5.88","spread":"2.11"},{"groupId":"OG002","value":"7.59","spread":"1.99"},{"groupId":"OG003","value":"13.75","spread":"1.90"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in HDL-C at Week 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.57","spread":"2.29"},{"groupId":"OG001","value":"6.04","spread":"2.18"},{"groupId":"OG002","value":"8.45","spread":"2.04"},{"groupId":"OG003","value":"14.18","spread":"1.95"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in VLDL-C at the Mean of Weeks 10 and 12","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.63","spread":"4.70"},{"groupId":"OG001","value":"7.92","spread":"4.43"},{"groupId":"OG002","value":"-17.55","spread":"4.19"},{"groupId":"OG003","value":"-16.09","spread":"3.99"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":164},"commonTop":["Diabetes mellitus","Upper respiratory tract infection","Nasopharyngitis","Hypertension","Cough"]}}}